| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Jun 24 | Jun 23 | Jun 22 |
| Issuance( Retirement)of Debt Net | -2.34 | -3.12 | -4.68 | -4.78 |
| Net Changein Cash | -56.46 | -196.69 | 116.02 | -144.64 |
| Cash Taxes Paid | 81.32 | 85.19 | 89.66 | 63.86 |
| Net Income/ Starting Line | 311.62 | 273.32 | 314.20 | 253.37 |
| Total Cash Dividends Paid | -232.40 | -414.99 | -93.79 | -283.85 |
| Changesin Working Capital | -155.13 | -97.30 | -119.70 | -111.15 |
| Cashfrom Operating Activities | 168.69 | 228.29 | 235.99 | 169.53 |
| Cashfrom Financing Activities | -234.74 | -418.11 | -98.47 | -288.63 |
| Depreciation/ Depletion | 16.69 | 27.40 | 28.10 | 27.08 |
| Other Investing Cash Flow Items Total | 18.15 | 14.86 | 20.98 | 12.38 |
| Capital Expenditures | -8.56 | -21.73 | -42.48 | -37.92 |
| period Type | - | - | - | - |
| Non- Cash Items | -4.49 | 24.87 | 13.39 | 0.23 |
| period Length | 9.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | 9.59 | -6.87 | -21.50 | -25.54 |
Procter & Gamble Health Dividend Procter & Gamble Health Bonus Procter & Gamble Health News Procter & Gamble Health AGM Procter & Gamble Health Rights Procter & Gamble Health Splits Procter & Gamble Health Board Meetings Procter & Gamble Health Key Metrics Procter & Gamble Health Shareholdings Procter & Gamble Health Profit Loss Procter & Gamble Health Balance Sheet Procter & Gamble Health Q1 Results Procter & Gamble Health Q2 Results Procter & Gamble Health Q3 Results Procter & Gamble Health Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks